ListarDAAPC-Artículos, capítulos... por tema "Urothelium"

Mostrando ítems 1-2 de 2

    • Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer 

      López-Beltrán, Antonio; Cimadamore, Alessia; Blanca, Ana; Massari, Francesco; Vau, Nuno; Scarpelli, Marina; Cheng, Liang; Montironi, Rodolfo (MDPI, 2021)
      A number of immune checkpoint inhibitors (ICIs) have been approved as first-line therapy in case of cisplatin-ineligible patients or as second-line therapy for patients with metastatic urothelial carcinoma (mUC) of the ...

    • Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma 

      Zizzi, Antonio; Montironi, Maria Alessandra; Mazzucchelli, Roberta; Scarpelli, Marina; López-Beltrán, Antonio; Cheng, Liang; Paone, Nicola; Castellini, Paolo; Montironi, Rodolfo (BioMed Central, 2013)
      Background/Aims: The chromatin remodeler DAXX, a predominantly nuclear protein, regulates the status of chromatin organization. The aim of this exploratory immunohistochemical study was to evaluate DAXX protein expression ...